Cargando…

What Should Be Done To Tackle Ghostwriting in the Medical Literature?

Background to the debate: Ghostwriting occurs when someone makes substantial contributions to a manuscript without attribution or disclosure. It is considered bad publication practice in the medical sciences, and some argue it is scientific misconduct. At its extreme, medical ghostwriting involves p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gøtzsche, Peter C, Kassirer, Jerome P, Woolley, Karen L, Wager, Elizabeth, Jacobs, Adam, Gertel, Art, Hamilton, Cindy
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	The PLoS Medicine Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634793/ https://www.ncbi.nlm.nih.gov/pubmed/19192943 http://dx.doi.org/10.1371/journal.pmed.1000023

Ejemplares similares

Is the “3 by 5” Initiative the Best Approach to Tackling the HIV Pandemic?
por: Kim, Jim Yong, et al.
Publicado: (2004)

Which New Approaches to Tackling Neglected Tropical Diseases Show Promise?
por: Spiegel, Jerry M., et al.
Publicado: (2010)

When Should Children with HIV Infection Be Started on Antiretroviral Therapy?
por: Welch, Steven B, et al.
Publicado: (2008)

Should Health Professionals Screen All Women for Domestic Violence?
por: Taket, Ann, et al.
Publicado: (2004)

Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises?
por: Emanuel, Ezekiel J, et al.
Publicado: (2006)

Should Data from Demographic Surveillance Systems Be Made More Widely Available to Researchers?
por: Chandramohan, Daniel, et al.
Publicado: (2008)

Should the Health Community Promote Smokeless Tobacco (Snus) as a Harm Reduction Measure?
por: Gartner, Coral E, et al.
Publicado: (2007)

Should Informed Consent for Cancer Treatment Include a Discussion about Hospital Outcome Disparities?
por: Housri, Nadine, et al.
Publicado: (2008)

Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?
por: McKinney, Ross, et al.
Publicado: (2005)

What Is the Best Approach to Treating Schizophrenia in Developing Countries?
por: Patel, Vikram, et al.
Publicado: (2007)

What Are the Roles and Responsibilities of the Media in Disseminating Health Information?
por: Schwitzer, Gary, et al.
Publicado: (2005)

What Are the Public Health Effects of Direct-to-Consumer Drug Advertising?
por: Almasi, Elizabeth A, et al.
Publicado: (2006)

What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin?
por: Abroms, Lorien, et al.
Publicado: (2006)

What Is the Best Strategy for Reducing Deaths from Heart Disease?
por: Makover, Michael E, et al.
Publicado: (2005)

What Are the Benefits and Risks of Fitting Patients with Radiofrequency Identification Devices
por: Levine, Mark, et al.
Publicado: (2007)

What Is the Optimal Therapy for Patients with H5N1 Influenza?
por: White, Nicholas J., et al.
Publicado: (2009)

In Global Health Research, Is It Legitimate To Stop Clinical Trials Early on Account of Their Opportunity Costs?
por: Lavery, James V., et al.
Publicado: (2009)

Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever
por: D'Acremont, Valérie, et al.
Publicado: (2009)

Abandoning Presumptive Antimalarial Treatment for Febrile Children Aged Less Than Five Years—A Case of Running Before We Can Walk?
por: English, Mike, et al.
Publicado: (2009)

Is Private Health Care the Answer to the Health Problems of the World's Poor?
por: Hanson, Kara, et al.
Publicado: (2008)

Is It Always Unethical to Use a Placebo in a Clinical Trial?
por: Stang, Andreas, et al.
Publicado: (2005)

Which Single Intervention Would Do the Most to Improve the Health of Those Living on Less Than $1 Per Day?
por: Yamey, Gavin
Publicado: (2007)

In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?
por: Guyatt, Gordon H, et al.
Publicado: (2008)

Is It Ethical to Use Enhancement Technologies to Make Us Better than Well?
por: Caplan, Arthur, et al.
Publicado: (2004)

Is It Ethical for Patients with Renal Disease to Purchase Kidneys from the World's Poor?
por: Bakdash, Tarif, et al.
Publicado: (2006)

Can Routine Commercial Cord Blood Banking Be Scientifically and Ethically Justified?
por: Fisk, Nicholas M, et al.
Publicado: (2005)

Was the “ABC” Approach (Abstinence, Being Faithful, Using Condoms) Responsible for Uganda's Decline in HIV?
por: Murphy, Elaine M, et al.
Publicado: (2006)

Do Electronic Health Records Help or Hinder Medical Education?
por: Peled, Jonathan U., et al.
Publicado: (2009)

Can We Systematically Review Studies That Evaluate Complex Interventions?
por: Shepperd, Sasha, et al.
Publicado: (2009)

Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008)
por: Hunt, Paul, et al.
Publicado: (2010)

Are Drug Companies Living Up to Their Human Rights Responsibilities? The Merck Perspective
por: Ritter, Geralyn S.
Publicado: (2010)

Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment
por: Gruskin, Sofia, et al.
Publicado: (2010)

Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One?
por: D'Arcy, Emma, et al.
Publicado: (2009)

Are Patents Impeding Medical Care and Innovation?
por: Gold, E. Richard, et al.
Publicado: (2010)

The Case for a Smoker's License
por: Chapman, Simon
Publicado: (2012)

The Case against a Smoker's License
por: Collin, Jeff
Publicado: (2012)

Have Online International Medical Journals Made Local Journals Obsolete?
por: Ofori-Adjei, David, et al.
Publicado: (2006)

Open Access As Public Policy
por: Gass, Andy
Publicado: (2004)

PLoS Medicine— A Medical Journal for the Internet Age
por: Eisen, Michael B, et al.
Publicado: (2004)

Baseline testing in cluster randomised controlled trials: should this be done?
por: Bolzern, Jaime E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ecuk1ps1ekdtsv27pkbpfkfgh